COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.

Latam Top

First-in-Human – Experimental mRNA HIV vaccine trial.

Moderna could start a Phase I trial of its mRNA HIV vaccine as early as this week, according to a update.


First-in-Human Trial – First Spanish Covid vaccine approved.

The candidate has been developed by Hipra, which says it will be able to produce 1.2 million doses by 2023.


Clinical Trials – Treatment for Chronic Kidney Disease.

Forxiga becomes the first new CDK therapy for adults to receive approval in the UK and EU in more than two decades.


Clinical trials – Study for Type 1 Diabetes medication.

A Phase II clinical trial that will test the efficacy of a medication for Type 1 Diabetes has been initiated.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.